
Offsetting NHS funding from existing services to pay for expensive new drugs could be harming the health of the nation, a study suggests.
The cost of innovative new medicines “do not always justify the benefits they offer”, researchers warned.

Offsetting NHS funding from existing services to pay for expensive new drugs could be harming the health of the nation, a study suggests.
The cost of innovative new medicines “do not always justify the benefits they offer”, researchers warned.